| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000030811 |
| Receipt No. | R000035016 |
| Scientific Title | Long term follow-up protocol of phase III study comparing second- and third-generation regimens with concurrent thoracic radiotherapy in unresectable stage III non-small cell lung cancer.(WJOG0105LFS) |
| Date of disclosure of the study information | 2018/01/15 |
| Last modified on | 2021/10/08 (Ver. 8) |
| Basic information | ||
| Public title | Long term follow-up protocol of phase III study comparing second- and third-generation regimens with concurrent thoracic radiotherapy in unresectable stage III non-small cell lung cancer.(WJOG0105LFS) | |
| Acronym | Follow up study of WJTOG0105 | |
| Scientific Title | Long term follow-up protocol of phase III study comparing second- and third-generation regimens with concurrent thoracic radiotherapy in unresectable stage III non-small cell lung cancer.(WJOG0105LFS) | |
| Scientific Title:Acronym | Follow up study of WJTOG0105 | |
| Region |
|
|
| Condition | ||
| Condition | Non-small cell lung cancer | |
| Classification by specialty |
|
|
| Classification by malignancy | Malignancy | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | The purpose of this study is that we investigate long term follow-up results of third-generation regimens with concurrent thoracic radiotherapy in unresectable stage III non-small cell lung cancer. |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Overall survival |
| Key secondary outcomes | Prgression-free survival, Pattern of relapse, Post treatment after progression, Late toxicity. |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | All cases of registerd with WJTOG0105. | |||
| Key exclusion criteria | None | |||
| Target sample size | 440 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | National Cancer Center Hospital East | ||||||
| Division name | Thoracic Surgery | ||||||
| Zip code | 277-8577 | ||||||
| Address | 6-5-1 Kashiwanoha, Kashiwa City, Chiba Prefecture, Japan | ||||||
| TEL | 04-7133-1111 | ||||||
| mtsuboi@east.ncc.go.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | West Japan Oncology Group | ||||||
| Division name | WJOG datacenter | ||||||
| Zip code | 556-0016 | ||||||
| Address | Namba Plaza Bldg. 304-1-5-7, Motomachi Naniwa-ku, Osaka 556-0016 JAPAN | ||||||
| TEL | 06-6633-7400 | ||||||
| Homepage URL | |||||||
| datacenter@wjog.jp | |||||||
| Sponsor | |
| Institute | West Japan Oncology Group |
| Institute | |
| Department | |
| Funding Source | |
| Organization | None |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital |
| Address | 3-18-22 Honkomagome, Bunkyo-ku, Tokyo 113-8677 |
| Tel | 03-3823-2101 |
| yzenke@cick.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | 331 |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | Retrospective analysis of long-term follow-up survival with WJTOG0105. |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000035016 |